Glycogen synthase kinase-3 facilitates con a-induced IFN-γ-mediated immune hepatic injury

Journal of Immunology

Volumn 187, Issue 7, 2011, Pages 3867-3877

  Tsai, Cheng Chieh ^a,b   Huang, Wei Ching ^a   Chen, Chia Ling ^a   Hsieh, Chia Yuan ^a   Lin, Yee Shin ^a   Chen, Shun Hua ^a   Yang, Kao Chi ^a   Lin, Chiou Feng ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; FAS ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GLYCOGEN SYNTHASE KINASE 3; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; STAT1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; C57BL 6 MOUSE; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INHIBITION; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNE INJURY; IN VITRO STUDY; INFLAMMATION; LIVER CELL; LIVER INJURY; LIVER NECROSIS; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL SEPARATION; CONCANAVALIN A; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLYCOGEN SYNTHASE KINASE 3; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; LIVER; LIVER DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGENS; SIGNAL TRANSDUCTION;

EID: 80053554576     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100770     Document Type: Article

References (82)

1. Antoniades, C. G., P. A. Berry, J. A. Wendon, and D. Vergani. 2008. The importance of immune dysfunction in determining outcome in acute liver failure. J. Hepatol. 49: 845-861.
2. Dong, Z., H. Wei, R. Sun, and Z. Tian. 2007. The roles of innate immune cells in liver injury and regeneration. Cell. Mol. Immunol. 4: 241-252.
3. Kita, H., I. R. Mackay, J. Van De Water, and M. E. Gershwin. 2001. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology 120: 1485-1501. (Pubitemid 32322324)
4. Tiegs, G., J. Hentschel, and A. Wendel. 1992. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90: 196-203.
5. Bonder, C. S., M. N. Ajuebor, L. D. Zbytnuik, P. Kubes, and M. G. Swain. 2004. Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis. J. Immunol. 172: 45-53. (Pubitemid 38020454)
6. Schümann, J., D. Wolf, A. Pahl, K. Brune, T. Papadopoulos, N. Van Rooijen, and G. Tiegs. 2000. Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am. J. Pathol. 157: 1671-1683.
7. Hatano, M., S. Sasaki, S. Ohata, Y. Shiratsuchi, T. Yamazaki, K. Nagata, and Y. Kobayashi. 2008. Effects of Kupffer cell-depletion on concanavalin A-induced hepatitis. Cell. Immunol. 251: 25-30.
8. Takeda, K., Y. Hayakawa, L. Van Kaer, H. Matsuda, H. Yagita, and K. Okumura. 2000. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl. Acad. Sci. USA 97: 5498-5503. (Pubitemid 30313747)
9. Swain, M. G. 2008. Hepatic NKT cells: friend or foe? Clin. Sci. 114: 457-466. (Pubitemid 351548754)
10. Santodomingo-Garzon, T., J. Han, T. Le, Y. Yang, and M. G. Swain. 2009. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice. Hepatology 49: 1267-1276.
11. Gantner, F., M. Leist, A. W. Lohse, P. G. Germann, and G. Tiegs. 1995. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21: 190-198.
12. Küsters, S., F. Gantner, G. Künstle, and G. Tiegs. 1996. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 111: 462-471. (Pubitemid 26256736)
13. Abe, T., H. Kawamura, S. Kawabe, H. Watanabe, F. Gejyo, and T. Abo. 2002. Liver injury due to sequential activation of natural killer cells and natural killer T cells by carrageenan. J. Hepatol. 36: 614-623. (Pubitemid 34499398)
14. -/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J. Immunol. 159: 1418-1428.
15. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume. 2004. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75: 163-189. (Pubitemid 38174573)
16. Schoenborn, J. R., and C. B. Wilson. 2007. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 96: 41-101. (Pubitemid 350018717)
17. Bach, E. A., M. Aguet, and R. D. Schreiber. 1997. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15: 563-591. (Pubitemid 27169292)
18. Platanias, L. C. 2005. Mechanisms of type-I- and type-II-interferon- mediated signalling. Nat. Rev. Immunol. 5: 375-386. (Pubitemid 40685987)
19. Leifeld, L., S. Cheng, J. Ramakers, F. L. Dumoulin, C. Trautwein, T. Sauerbruch, and U. Spengler. 2002. Imbalanced intrahepatic expression of interleukin 12, interferon gamma, and interleukin 10 in fulminant hepatitis B. Hepatology 36: 1001-1008.
20. Schweyer, S., S. Mihm, H. J. Radzun, H. Hartmann, and A. Fayyazi. 2000. Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection. Gut 46: 255-259. (Pubitemid 30305854)
21. Miller, C. H., S. G. Maher, and H. A. Young. 2009. Clinical use of interferon-gamma. Ann. N. Y. Acad. Sci. 1182: 69-79.
22. Hong, F., B. Jaruga, W. H. Kim, S. Radaeva, O. N. El-Assal, Z. Tian, V. A. Nguyen, and B. Gao. 2002. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J. Clin. Invest. 110: 1503-1513. (Pubitemid 35396921)
23. Siebler, J., S. Wirtz, S. Klein, M. Protschka, M. Blessing, P. R. Galle, and M. F. Neurath. 2003. A key pathogenic role for the STAT1/T-bet signaling pathway in T-cell-mediated liver inflammation. Hepatology 38: 1573-1580. (Pubitemid 37466983)
24. Jaruga, B., F. Hong, W. H. Kim, and B. Gao. 2004. IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G1044-G1052. (Pubitemid 39423697)
25. Tagawa, Y., S. Kakuta, and Y. Iwakura. 1998. Involvement of Fas/Fas ligand system-mediated apoptosis in the development of concanavalin A-induced hepatitis. Eur. J. Immunol. 28: 4105-4113. (Pubitemid 28558640)
26. Roth, E., and H. Pircher. 2004. IFN-gamma promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells. J. Immunol. 172: 1588-1594. (Pubitemid 38116805)
27. Kano, A., T. Haruyama, T. Akaike, and Y. Watanabe. 1999. IRF-1 is an essential mediator in IFN-gamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes. Biochem. Biophys. Res. Commun. 257: 672-677. (Pubitemid 29301501)
28. Seino, K., N. Kayagaki, K. Takeda, K. Fukao, K. Okumura, and H. Yagita. 1997. Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterology 113: 1315-1322. (Pubitemid 27418986)
29. Frame, S., and P. Cohen. 2001. GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359: 1-16. (Pubitemid 32939202)
30. Cohen, P., and S. Frame. 2001. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2: 769-776. (Pubitemid 33679839)
31. Jope, R. S., and G. V. Johnson. 2004. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29: 95-102. (Pubitemid 38186580)
32. Kockeritz, L., B. Doble, S. Patel, and J. R. Woodgett. 2006. Glycogen synthase kinase-3: an overview of an overachieving protein kinase. Curr. Drug Targets 7: 1377-1388. (Pubitemid 44718298)
33. Cross, D. A., D. R. Alessi, P. Cohen, M. Andjelkovich, and B. A. Hemmings. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789. (Pubitemid 26004411)
34. Pap, M., and G. M. Cooper. 1998. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J. Biol. Chem. 273: 19929-19932. (Pubitemid 28377539)
35. Hartigan, J. A., W. C. Xiong, and G. V. Johnson. 2001. Glycogen synthase kinase 3beta is tyrosine phosphorylated by PYK2. Biochem. Biophys. Res. Commun. 284: 485-489. (Pubitemid 32918003)
36. Cuzzocrea, S., C. Crisafulli, E. Mazzon, E. Esposito, C. Muià, M. Abdelrahman, R. Di Paola, and C. Thiemermann. 2006. Inhibition of glycogen synthase kinase-3beta attenuates the development of carrageenan-induced lung injury in mice. Br. J. Pharmacol. 149: 687-702. (Pubitemid 44748061)
37. Cuzzocrea, S., R. Di Paola, E. Mazzon, C. Crisafulli, T. Genovese, C. Muia, M. Abdelrahman, E. Esposito, and C. Thiemermann. 2007. Glycogen synthase kinase 3beta inhibition reduces the development of nonseptic shock induced by zymosan in mice. Shock 27: 97-107. (Pubitemid 44968017)
38. Cuzzocrea, S., T. Genovese, E. Mazzon, C. Crisafulli, R. Di Paola, C. Muià, M. Collin, E. Esposito, P. Bramanti, and C. Thiemermann. 2006. Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma. J. Pharmacol. Exp. Ther. 318: 79-89.
39. Cuzzocrea, S., T. Genovese, E. Mazzon, E. Esposito, C. Muià, M. Abdelrahman, R. Di Paola, P. Bramanti, and C. Thiemermann. 2007. Glycogen synthase kinase-3beta inhibition attenuates the development of bleomycin-induced lung injury. Int. J. Immunopathol. Pharmacol. 20: 619-630. (Pubitemid 47531065)
40. Cuzzocrea, S., E. Mazzon, R. Di Paola, C. Muia, C. Crisafulli, L. Dugo, M. Collin, D. Britti, A. P. Caputi, and C. Thiemermann. 2006. Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse. Clin. Immunol. 120: 57-67. (Pubitemid 43903390)
41. Cuzzocrea, S., E. Mazzon, E. Esposito, C. Muià, M. Abdelrahman, R. Di Paola, C. Crisafulli, P. Bramanti, and C. Thiemermann. 2007. Glycogen synthase kinase-3beta inhibition attenuates the development of ischaemia/reperfusion injury of the gut. Intensive Care Med. 33: 880-893. (Pubitemid 46675329)
42. Zhang, P., J. Katz, and S. M. Michalek. 2009. Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice. Mol. Immunol. 46: 677-687.
43. Bao, Z., S. Lim, W. Liao, Y. Lin, C. Thiemermann, B. P. Leung, and W. S. Wong. 2007. Glycogen synthase kinase-3beta inhibition attenuates asthma in mice. Am. J. Respir. Crit. Care Med. 176: 431-438. (Pubitemid 47358096)
44. Whittle, B. J., C. Varga, A. Pósa, A. Molnár, M. Collin, and C. Thiemermann. 2006. Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3beta. Br. J. Pharmacol. 147: 575-582. (Pubitemid 43355056)
45. Gao, H. K., Z. Yin, N. Zhou, X. Y. Feng, F. Gao, and H. C. Wang. 2008. Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis. J. Cardiovasc. Pharmacol. 52: 286-292.
46. Wang, Y., W. C. Huang, C. Y. Wang, C. C. Tsai, C. L. Chen, Y. T. Chang, J. I. Kai, and C. F. Lin. 2009. Inhibiting glycogen synthase kinase-3 reduces endotoxaemic acute renal failure by down-regulating inflammation and renal cell apoptosis. Br. J. Pharmacol. 157: 1004-1013.
47. Dugo, L., M. Collin, D. A. Allen, N. S. Patel, I. Bauer, E. M. Mervaala, M. Louhelainen, S. J. Foster, M. M. Yaqoob, and C. Thiemermann. 2005. GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat. Crit. Care Med. 33: 1903-1912. (Pubitemid 41306508)
48. Dugo, L., M. Abdelrahman, O. Murch, E. Mazzon, S. Cuzzocrea, and C. Thiemermann. 2006. Glycogen synthase kinase-3beta inhibitors protect against the organ injury and dysfunction caused by hemorrhage and resuscitation. Shock 25: 485-491.
49. Dugo, L., M. Collin, and C. Thiemermann. 2007. Glycogen synthase kinase 3beta as a target for the therapy of shock and inflammation. Shock 27: 113-123. (Pubitemid 46105826)
50. Shinohara, M., M. D. Ybanez, S.Win, T. A. Than, S. Jain,W. A. Gaarde, D. Han, and N. Kaplowitz. 2010. Silencing glycogen synthase kinase-3beta inhibits acetaminophen hepatotoxicity and attenuates JNK activation and loss of glutamate cysteine ligase and myeloid cell leukemia sequence 1. J. Biol. Chem. 285: 8244-8255.
51. Hu, X., P. K. Paik, J. Chen, A. Yarilina, L. Kockeritz, T. T. Lu, J. R. Woodgett, and L. B. Ivashkiv. 2006. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24: 563-574. (Pubitemid 43728157)
52. Hu, X., J. Chen, L. Wang, and L. B. Ivashkiv. 2007. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J. Leukoc. Biol. 82: 237-243. (Pubitemid 47230632)
53. Beurel, E., and R. S. Jope. 2008. Differential regulation of STAT family members by glycogen synthase kinase-3. J. Biol. Chem. 283: 21934-21944.
54. Lin, C. F., C. C. Tsai, W. C. Huang, C. Y. Wang, H. C. Tseng, Y. Wang, J. I. Kai, S. W. Wang, and Y. L. Cheng. 2008. IFN-gamma synergizes with LPS to induce nitric oxide biosynthesis through glycogen synthase kinase-3-inhibited IL-10. J. Cell. Biochem. 105: 746-755.
55. Tsai, C. C., J. I. Kai, W. C. Huang, C. Y. Wang, Y. Wang, C. L. Chen, Y. T. Fang, Y. S. Lin, R. Anderson, S. H. Chen, et al. 2009. Glycogen synthase kinase-3beta facilitates IFN-gamma-induced STAT1 activation by regulating Src homology-2 domain-containing phosphatase 2. J. Immunol. 183: 856-864.
56. Kai, J. I., W. C. Huang, C. C. Tsai, W. T. Chang, C. L. Chen, and C. F. Lin. 2010. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis. J. Cell. Biochem. 111: 1522-1530.
57. Hu, X., and L. B. Ivashkiv. 2009. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 31: 539-550.
58. Beurel, E., S. M. Michalek, and R. S. Jope. 2010. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol. 31: 24-31.
59. Wang, H., J. Brown, and M. Martin. 2011. Glycogen synthase kinase 3: a point of convergence for the host inflammatory response. Cytokine 53: 130-140.
60. Takada, Y., X. Fang, M. S. Jamaluddin, D. D. Boyd, and B. B. Aggarwal. 2004. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J. Biol. Chem. 279: 39541-39554. (Pubitemid 39258221)
61. Martin, M., K. Rehani, R. S. Jope, and S. M. Michalek. 2005. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6: 777-784. (Pubitemid 43090463)
62. Huang, W. C., Y. S. Lin, C. Y. Wang, C. C. Tsai, H. C. Tseng, C. L. Chen, P. J. Lu, P. S. Chen, L. Qian, J. S. Hong, and C. F. Lin. 2009. Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells. Immunology 128: e275-e286.
63. Eldar-Finkelman, H. 2002. Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol. Med. 8: 126-132. (Pubitemid 34532638)
64. Morita, M., Y. Watanabe, and T. Akaike. 1994. Inflammatory cytokines upregulate intercellular adhesion molecule-1 expression on primary cultured mouse hepatocytes and T-lymphocyte adhesion. Hepatology 19: 426-431. (Pubitemid 24046788)
65. Sun, R., Z. Tian, S. Kulkarni, and B. Gao. 2004. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners. J. Immunol. 172: 5648-5655. (Pubitemid 38542068)
66. Skurat, A. V., and P. J. Roach. 1995. Phosphorylation of sites 3a and 3b (Ser640 and Ser644) in the control of rabbit muscle glycogen synthase. J. Biol. Chem. 270: 12491-12497.
67. Li, B., R. Sun, H. Wei, B. Gao, and Z. Tian. 2006. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism. Hepatology 43: 1211-1219. (Pubitemid 43980099)
68. Szabo, S. J., S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
69. Lin, T., L. Genestier, M. J. Pinkoski, A. Castro, S. Nicholas, R. Mogil, F. Paris, Z. Fuks, E. H. Schuchman, R. N. Kolesnick, and D. R. Green. 2000. Role of acidic sphingomyelinase in Fas/CD95-mediated cell death. J. Biol. Chem. 275: 8657-8663. (Pubitemid 30180216)
70. Küsters, S., G. Tiegs, L. Alexopoulou, M. Pasparakis, E. Douni, G. Künstle, H. Bluethmann, A. Wendel, K. Pfizenmaier, G. Kollias, and M. Grell. 1997. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur. J. Immunol. 27: 2870-2875. (Pubitemid 27478356)
71. Mizuhara, H., M. Uno, N. Seki, M. Yamashita, M. Yamaoka, T. Ogawa, K. Kaneda, T. Fujii, H. Senoh, and H. Fujiwara. 1996. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 23: 1608-1615. (Pubitemid 26181246)
72. Hoeflich, K. P., J. Luo, E. A. Rubie, M. S. Tsao, O. Jin, and J. R. Woodgett. 2000. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406: 86-90. (Pubitemid 30460216)
73. Schwabe, R. F., and D. A. Brenner. 2002. Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 283: G204-G211. (Pubitemid 34666179)
74. Martinez, A. 2008. Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs. Med. Res. Rev. 28: 773-796.
75. Maurer, U., C. Charvet, A. S. Wagman, E. Dejardin, and D. R. Green. 2006. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol. Cell 21: 749-760. (Pubitemid 43376126)
76. Ishida, Y., T. Kondo, T. Ohshima, H. Fujiwara, Y. Iwakura, and N. Mukaida. 2002. A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J. 16: 1227-1236. (Pubitemid 34815410)
77. Vick, B., A. Weber, T. Urbanik, T. Maass, A. Teufel, P. H. Krammer, J. T. Opferman, M. Schuchmann, P. R. Galle, and H. Schulze-Bergkamen. 2009. Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes. Hepatology 49: 627-636.
78. Desbois-Mouthon, C., M. J. Blivet-Van Eggelpoel, E. Beurel, M. Boissan, R. Delelo, A. Cadoret, and J. Capeau. 2002. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells. Hepatology 36: 1528-1536. (Pubitemid 35403543)
79. Kim, W. H., F. Hong, S. Radaeva, B. Jaruga, S. Fan, and B. Gao. 2003. STAT1 plays an essential role in LPS/D-galactosamine-induced liver apoptosis and injury. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G761-G768. (Pubitemid 37151238)
80. Townsend, M. J., A. S. Weinmann, J. L. Matsuda, R. Salomon, P. J. Farnham, C. A. Biron, L. Gapin, and L. H. Glimcher. 2004. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 20: 477-494. (Pubitemid 38482125)
81. Boothby, M. 2009. The calculus of integrating differentiation: timing control of T-bet. Immunity 30: 666-668.
82. Hwang, E. S., J. H. Hong, and L. H. Glimcher. 2005. IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508. J. Exp. Med. 202: 1289-1300.